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Skin Metastasis as the Initial Manifestation of Poorly 
Differentiated Thyroid Carcinoma  
Dear Editor,
   
 Poorly differentiated thyroid carcinoma (PDTC) is a 
rare and clinically aggressive thyroid cancer of follicu-
lar cell origin. This thyroid tumor can also arise from 
Hürthle cell or papillary thyroid carcinoma (1). PDTC 
accounts for 4-7% of all thyroid cancers and it is twice 
as common in men of a mean age of 55.7 years (1,2). 
According to the World Health Organization (WHO) 
definition, PDTC has 2 histomorphologic subtypes: 
insular and noninsular (1). However, based on clinical 
features, PDTC has a morphologically and behavior-
ally intermediate position between well differenti-
ated (follicular and papillary) and undifferentiated 
(anaplastic) thyroid carcinoma (3,4). Notably, PDTC 
often presents in an advanced stage and has a pro-
pensity for local recurrence,   tending to metastasize 
to regional lymph nodes, the lungs, and bone (1). 
Accordingly, this thyroid tumor has a rapid and fatal 
outcome despite appropriate treatment (3).
Skin metastases are a rare phenomenon in PDTC, 
representing 0.7-2.0% of all cutaneous malignant 
neoplasms (5). Skin metastasis from thyroid carci-
noma is rare and occasionally represents the initial 
manifestation of an occult thyroid carcinoma (5,6). To 
the best of our knowledge, only a few cases of cuta-
neous metastasis from PDTC have been reported in 
the English-language literature until 2012. Herein, we 
report on an additional case of PDTC with metastasis 
to the skin as a presenting sign of thyroid cancer.
A 78-year-old man presented with multiple skin 
nodules on the scalp, forehead, and chin. The patient 
presented with a progressive mass on the right side 
of the thyroid lobe that had developed 3 months 
previously. The patient had a history of odinophagia, 
weight loss, and decreased appetite. He had been 
a smoker for 40 years, but had no familial history of 
thyroid disease or exposure to radiation. On examina-
tion, multiple erythematous and tender nodules were 
found on the scalp, forehead, and chin (Figure 1). Thy-
roid examination revealed both sides of the thyroid 
gland were enlarged, as well as fixed and firm nod-
ules in the right thyroid lobe without any evidence 
of thyrotoxicosis or hypothyroidism. Additionally, 
there was a palpable cervical lymphadenopathy on 
the right side. Routine hematological and biochemi-
cal thyroid hormones profile tests were within nor-
mal ranges. X-ray of the chest showed multiple foci of 
calcification on both lungs, but skull X-ray, abdomen 
ultrasonography, and brain computered tomography 
(CT) were normal.
A thyroid scan revealed a cold nodule in the right 
lobe of the thyroid gland. A fine needle aspiration 
of the thyroid nodule was performed, and stained 
with Papanicolaou stain. Cytology smears revealed a 
mainly bloody background  with few atypical cells in-
dicating a neoplastic process. One of the scalp lesions 
was excised due to the clinical diagnosis of meta-
static skin tumor and adenexal tumor, and submitted 
for histopathological examination. Histology of the 
lesion showed normal epidermis with presence of 
grenz zone between tumoral cells (Figure 2), as well as 
neoplastic cells arranged in nests within the delicate 
vascular stroma with minimal nuclear pleomorphic 
and small, but distinct nucleoli and clear cytoplasms. 
Additionally, solid nests, trabeculae, and a cribriform 
arrangement of cells with micro follicle formation 
and a wide area of necrosis were seen. These findings 
were consistent with poorly differentiated carcinoma 
(insular carcinoma). On the other hand, immunohis-
tochemical tests were positive for thyroid transcrip-
tion factor 1 (TTF-1) and thyroglobulin staining. 
Although the surgery was a difficult task because 
of the extensive thyroid metastases of tumor cells, a 
right-sided thyroid lobectomy and modified radical 
neck dissection was performed. The patient was dis-
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charged from the hospital and referred to the oncol-
ogy department for palliative treatment. Follow-up 
was continued for 4 months after the primary diag-
nosis of skin metastases, but he died due to the wide-
spread metastases of tumor cells.
Thyroid carcinoma metastases to the skin are a 
rare clinical entity, particularly as a presenting feature 
of underlying malignancy (5,6). In a recent study that 
included 3848 patients with metastatic carcinoma, 
no thyroid neoplasms were observed (7). Dahl et 
al. reviewed English-language literature since 1964 
onwards and found 43 cases of thyroid carcinoma 
with cutaneous metastases among the 39 patients 
for whom histological findings of the tumor were 
reported (7). Papillary neoplasm was most common 
(41%), followed by follicular (28%), anaplastic (15%), 
and medullary carcinoma (15%). In that study, thyroid 
cancer was diagnosed before cutaneous metastasis 
in most cases, with a single case where cutaneous 
metastasis preceded the diagnosis of the primary 
thyroid cancer (7). 
Thyroid metastatic skin lesions are typically pres-
ent as slowly growing erythematous or purple nod-
ules that are tender, may be itchy, and can ulcerate 
(6,8). Studies have shown that the scalp is the most 
common site, being involved in approximately two 
thirds of thyroid carcinoma cases (8,9).
Immonoperoxidase methods have been used to 
demonstrate that thyroglobulin, a 670 kd glycopro-
tein synthesized in the cytoplasm of follicular thyroid 
epithelial cells, is present in normal thyroid glands, 
goiters, thyroiditis, and some thyroid carcinomas. 
Thyroglobulin is detectable in all cases of follicular 
carcinoma and 95% of papillary carcinoma but is ab-
sent in anaplastic thyroid carcinoma (7).
Thyroid transcription factor-1 (TTF–1) is a nucle-
ar protein expressed in follicular cells of the thyroid 
gland and also in lung and brain cells. This factor is a 
good marker of thyroid differentiation and detection 
of origin in metastatic carcinomas (1). The sensitiv-
ity for thyroglobulin and TTF–1 alone for thyroid tu-
mor is 90.5% and 92.9%, respectively, and combined 
monitoring of the two increases the sensitivity for 
detection of thyroid carcinoma (10). Survival after the 
diagnosis of PDTC shows a poor outcome. The mean 
5-year survival of affected patients is 71.6% and the 
10- year survival rate  is 46.3% (4). In our patient, skin 
metastases stained positive for TTF–1 and thyroglob-
ulin. The tumor was aggressive and led to death 4 
months after the initial diagnosis and treatment. 
In conclusion, we report on one more case of PDTC 
in an old man with multiple skin metastases. 
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